Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

1,3-Butadiene working group report

I D Adler1, J Cochrane, S Osterman-Golkar

  • 1GSF-Institut für Säugetiergenetik, Oberschleissheim, Germany.

Mutation Research
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up.

Infection·2024
Same author

Measurement of the <math></math> energy spectrum with IceCube-79: IceCube Collaboration.

The European physical journal. C, Particles and fields·2020
Same author

Measurement of Atmospheric Neutrino Oscillations at 6-56 GeV with IceCube DeepCore.

Physical review letters·2018
Same author

A doubly responsive probe for the detection of Cys4-tagged proteins.

Chemical communications (Cambridge, England)·2015
Same author

Internal structure of the Community Assessment of Psychic Experiences-Positive (CAPE-P15) scale: Evidence for a general factor.

Schizophrenia research·2015
Same author

Laryngeal cuff pressure - an equilibrium recoil technique.

Anaesthesia·2015
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

1,3-Butadiene (BD) metabolism and genotoxicity show species differences, with mice being more susceptible than rats and humans. Current data are insufficient for accurate human genetic risk assessment, necessitating further research.

Area of Science:

  • Toxicology
  • Environmental Health
  • Genetics

Background:

  • 1,3-Butadiene (BD) is an industrial chemical with known toxicological concerns.
  • Understanding its metabolism and genotoxicity across species is crucial for risk assessment.

Purpose of the Study:

  • To review and summarize available in vivo metabolism, adduct formation, and genotoxicity data for 1,3-butadiene (BD) in rodents and humans.
  • To assess the sufficiency of current data for estimating human genetic risk using the parallelogram model.

Main Methods:

  • Review of existing literature on 1,3-butadiene (BD) metabolism, including cytochrome P-450 pathways and metabolite formation (epoxybutene, diepoxybutane).
  • Analysis of species-specific adduct formation data (hemoglobin, DNA) and genotoxicity studies (in vivo rodent tests, human cytogenetic studies).

Related Experiment Videos

  • Evaluation of data for applying the parallelogram model and estimation of the doubling dose for hprt mutations.

    • Main Results:

    • Significant species differences observed in BD metabolism, with mice favoring oxidation and rats/humans favoring hydrolysis.
    • Adduct formation patterns showed mice > rats > humans; genotoxicity was positive in mice but negative in rats.
    • Human studies showed no cytogenetic effects, though some reported elevated hprt variant levels.

    Conclusions:

    • Existing data are insufficient for accurate human genetic risk estimation using the parallelogram model.
    • A tentative doubling dose for hprt mutations was estimated but requires further validation due to caveats.
    • Urgent research needs include detailed metabolic pathway identification, polymorphism studies, adduct analysis, mutational spectra, and germ cell studies in relevant species and humans.